Sponsor GmbH
37
5
8
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
24.3%
9 terminated/withdrawn out of 37 trials
62.5%
-24.0% vs industry average
22%
8 trials in Phase 3/4
0%
0 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (37)
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
Role: collaborator
A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors
Role: collaborator
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Role: collaborator
A Bioequivalence Study of JS005 Pre-filled Syringe and JS005 Auto-injector
Role: collaborator
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Role: collaborator
A Study of WJ05129 in Advanced Malignant Solid Tumors
Role: collaborator
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
Role: collaborator
A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer
Role: collaborator
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）
Role: collaborator
The Mass Balance Study of [14C]JT001
Role: collaborator
JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations
Role: collaborator
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
Role: collaborator
Effects of Taichi Exercises on Cardiorespiratory Fittness
Role: collaborator
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
Role: collaborator
A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
Role: collaborator
A Pharmacokinetic Study of JS002 in Healthy Subjects
Role: collaborator
Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas
Role: collaborator
The Effect of Placental Cord Drainage on Postpartum Blood Loss
Role: collaborator
A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
Role: collaborator
A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function
Role: collaborator